Nav: Home

Current Prostate Cancer News and Events | Page 2

Current Prostate Cancer News and Events, Prostate Cancer News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer
The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical trial NRG-GOG 0258, which showed that carboplatin and paclitaxel chemotherapy preceded by radiotherapy with concurrent cisplatin, or combined modality therapy, did not significantly increase recurrence-free survival for women with stage 3-4A endometrial cancer when compared to chemotherapy with carboplatin and paclitaxel alone. (2019-06-13)
New finding: Biomarker indicates tumor aggressiveness and poor prognosis in men with prostate cancer
Mortality due to prostate cancer is usually related to its likelihood to metastasize, especially to bone. (2019-06-12)
Community pharmacies make a lifestyle impact for patients with prostate cancer
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research in the British Medical Journal reports. (2019-06-12)
Study shows more effective method for detecting prostate cancer
Each year, 1 million men in the US undergo biopsies for prostate cancer. (2019-06-12)
Novel agent reactivates an immune call by LIF blockade
Promising new therapy with a dual mechanism of action to eliminate cancer stem cells and activate the immune system now in clinical development. (2019-06-11)
Cancer survivors predicted to number over 22 million by 2030
There were more than 16.9 million Americans with a history of cancer on Jan. (2019-06-11)
Body fat distribution linked to higher risk of aggressive prostate cancer
In the first prospective study of directly measured body fat distribution and prostate cancer risk, investigators found that higher levels of abdominal and thigh fat are associated with an increased risk of aggressive prostate cancer. (2019-06-10)
Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer
Researchers at SMU's Center for Drug Discovery, Design and Delivery (CD4) have succeeded in lab testing the use of chemotherapy with a specific protein inhibitor so that the chemotherapeutic is better absorbed by drug-resistant cancer cells without harming healthy cells. (2019-06-07)
Listening to music eases pain and other symptoms in patients with breast cancer
A European Journal of Cancer Care study found that listening to music at home reduced the severity of symptoms, pain intensity, and fatigue experienced by patients with breast cancer. (2019-06-05)
Zebrafish capture a 'window' on the cancer process
Cancer-related inflammation impacts significantly on cancer development and progression. New research has observed in zebrafish, for the first time, that inflammatory cells use weak spots or micro-perforations in the extracellular matrix barrier layer to access skin cancer cells. (2019-06-04)
Patients who received PBI without chemotherapy experienced less fatigue, slightly poorer cosmesis
Patient-reported outcome (PRO) data indicates that partial breast irradiation (PBI) is more convenient than whole breast irradiation (WBI) for women with breast cancer who do not receive adjuvant chemotherapy. (2019-06-03)
NRG Oncology trial sets new standard regimen for women with uterine carcinosarcomas
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide (PI) in women with stage I-IV, recurrent carcinosarcoma of the uterus or ovary, indicate that the PC combination treatment should be considered a standard of care for this patient population. (2019-06-03)
International clinical trial of new drug for men with advanced prostate cancer yields strong result
First results of phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers. (2019-06-03)
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology (ASCO) Annual Meeting. (2019-06-02)
NRG oncology trial of metformin for non-small cell lung cancer
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC). (2019-06-01)
NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe
Results from the first experimental arm using veliparib as part of total neoadjuvant therapy (induction chemotherapy followed by chemoradiotherapy and surgery; TNT) in patients with locally advanced rectal adenocarcinoma on the NRG Oncology Phase II clinical trial NRG-GI002 were recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. (2019-06-01)
Men who choose active surveillance for early prostate cancer often don't follow monitoring rules
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study suggest that not enough patients who choose active surveillance instead of treatment for early-stage prostate cancer may be following recommended monitoring guidelines. (2019-05-31)
Stand up to cancer-funded research to be presented at ASCO May 31-June 4 in Chicago
SU2C supported researchers will present work on pediatric brain tumors, cfDNA for early cancer detection, dual blockade of CTLA-4 and PD-1 in mCRC, cancer interception of pancreatic and lung cancers, machine learning RECIST in RWE study of lung cancer, and molecular markers of response to neoadjuvant nivolumab in resectable NSCLC. (2019-05-30)
ASCO 2019: Delays lead to late-stage diagosis of young people with colorectal cancer
Median 294 days passed between the first time patients noticed rectal bleeding and the time they were diagnosed. (2019-05-29)
Study finds how prostate cancer cells mimic bone when they metastasize
In a study published online Tuesday in the journal PLOS ONE, Duke Cancer Institute researchers describe how prostate cancer cells develop the ability to mimic bone-forming cells called osteoblasts, enabling them to proliferate in the bone microenvironment. (2019-05-28)
Lifting the lid on bladder cancer support
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence. (2019-05-28)
PSA, a prostate cancer marker, activates vascular and lymphangiogenic growth factors
A new study indicates that PSA, a prostate cancer marker, is one of the catalysts that activate vascular endothelial and lymphangiogenic growth factors which contribute to the spread of cancer. (2019-05-24)
New 3D-printed technology lowers cost of common medical test
A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid 'washing the dishes' led University of Connecticut researchers to develop a new technology that reduces cost and time. (2019-05-22)
Using fruit flies to identify new treatment for a colorectal cancer patient
Erdem Bangi and colleagues demonstrate a new approach to developing personalized therapy for a patient with treatment-resistant colorectal cancer: using a fruit fly genetically modified with a patient's own cancer mutations to test candidate treatments. (2019-05-22)
Black men less likely than nonblack men to adopt active surveillance
At a time when a growing number of men with prostate cancer considered 'low risk' are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease. (2019-05-22)
New technique promises improved metastatic prostate cancer detection
Results reported in Biomicrofluidics promise a new way to detect prostate cancer through a simple device, which forces cell samples through channels less than 10 microns wide. (2019-05-21)
Protein that hinders advancement of prostate cancer identified
Researchers at Boston University School of Medicine (BUSM) have discovered that blocking a specific protein, may be a promising strategy to prevent the spread of castration-resistant prostate cancer (CRPC). (2019-05-20)
Johns Hopkins researchers find widely 'inconsistent' use of antibodies in lab experiments
Scientists at the Johns Hopkins Kimmel Center say they have affirmed widespread inconsistencies in the use of a common laboratory procedure called immunohistochemical staining, and say the variations are making many laboratory experiments unreliable. (2019-05-15)
Researchers identify new therapeutic target for metastatic prostate cancer
Researchers in New York have found that treating human prostate cancer cells with a drug that targets a protein called PHLPP2 may prevent the cancer cells from spreading to other organs in the body. (2019-05-15)
Enzyme PHLPP2 could be a viable drug target for treating prostate cancer
Researchers propose a new druggable target that can put a damper on the spread of prostate cancer. (2019-05-15)
Yale study identifies how cancer drug inhibits DNA repair in cancer cells
According to researchers at Yale Cancer Center, a cancer drug thought to be of limited use possesses a superpower of sorts: It is able to stop certain cancer cells from repairing their DNA in order to survive. (2019-05-15)
Rates of long-term opiate use rises in Medicare cancer survivors each year after diagnosis
Using Medicare data, new findings from The University of Texas Medical Branch at Galveston show for the first time that the rates of long term opiate therapy for older cancer survivors remain high for at least five years in cancer survivors. (2019-05-14)
New Mexico cancer patients have lower survival rate, study finds
Researchers at the Burrell College of Osteopathic Medicine (BCOM) have found that cancer patients in New Mexico have lower chances of survival when compared to the rest of the nation. (2019-05-13)
New insights into treatment targets for men with advanced prostate cancers
A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. (2019-05-13)
Measuring chromosome imbalance could clarify cancer prognosis
Researchers have found that higher levels of aneuploidy lead to much greater lethality among prostate cancer patients. (2019-05-13)
Biomarker may help identify men with prostate cancer at greater risk of tumor metastasis
Ten percent of patients with prostate cancer develop locally invasive and metastatic disease, which increases the severity of the disease and likelihood of death and limits treatment options. (2019-05-09)
Diabetes linked to numerous cancers in large Chinese study
A new Journal of Diabetes study from China, which has the highest number of people with diabetes among all countries, found that type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of cancer in women. (2019-05-09)
Statins linked to lower risk of early death in patients with colorectal cancer
Use of statins before or after a diagnosis of colorectal cancer was linked with a lower risk of premature death, both from cancer and from other causes, in a Cancer Medicine analysis of published studies. (2019-05-09)
Inflammatory bowel disease during childhood linked to higher cancer rates and early death
A new Alimentary Pharmacology & Therapeutics study revealed an increased risk of cancer and early death in individuals who developed inflammatory bowel disease-including ulcerative colitis (UC) and Crohn's disease (CD) -- during childhood. (2019-05-09)
North York General study shows safest method for prostate cancer biopsies
Only one percent of testing for prostate cancer in North America is done using TPBx. (2019-05-09)
Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...